UnitedHealth Group (UNH) Q2 Earnings Lag Estimates

Core Viewpoint - UnitedHealth Group reported quarterly earnings of $4.08 per share, missing the Zacks Consensus Estimate of $4.84 per share, and down from $6.8 per share a year ago, indicating an earnings surprise of -15.70% [1][2] Financial Performance - The company posted revenues of $111.62 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.06%, and up from $98.86 billion year-over-year [2] - Over the last four quarters, UnitedHealth has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Performance - UnitedHealth shares have declined approximately 44.2% since the beginning of the year, contrasting with the S&P 500's gain of 8.6% [3] - The current Zacks Rank for UnitedHealth is 4 (Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $4.93 on revenues of $113.13 billion, and for the current fiscal year, it is $21.15 on revenues of $448.53 billion [7] - The trend of estimate revisions for UnitedHealth was unfavorable prior to the earnings release, which may impact future stock movements [5][6] Industry Context - The Medical - HMOs industry, to which UnitedHealth belongs, is currently in the bottom 4% of the Zacks industry rankings, suggesting potential challenges ahead [8] - The performance of UnitedHealth's stock may be influenced by the overall outlook for the industry [8]